Registry Study on Respiratory Monogenic Diseases in Chinese Children

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-18
SponsorKunling Shen

About this trial

This study is a multicenter, prospective cohort study of patients diagnosed with respiratory monogenic diseases, the clinical information of recruited patients, including clinical manifestations, lung function, chest imaging, quality of life and other indicators, will be followed for 5 years.

Eligibility criteria

Qualifiers

Age: 0-18 years, male and female.

Any organ system symptoms consistent with the diagnostic points of respiratory monogenic diseases.

Agree to retain specimens related to disease research and agree to store the specimens in the sample bank.

willing and able to cooperate with long-term follow-up.

Disqualifiers

It is unable to provide complete medical records or the current condition can not accept the diagnosis process

She or he cannot agree to participate in the study.

Trial design

Treatments tested in this trial

Treatment groups

200 Participants
are divided into 1 treatment group

Sponsors and collaborators

Kunling Shen

Lead sponsor

Beijing Children's Hospital

Sponsor institution

Capital Institute of Pediatrics, China

Collaborator

Shengjing Hospital

Collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Collaborator

The Children's Hospital of Zhejiang University School of Medicine

Collaborator

Children's Hospital of Chongqing Medical University

Collaborator

The first clinical college of Guangzhou medical university

Collaborator

Guangzhou Women and Children's Medical Center

Collaborator

Yuying Children's Hospital of Wenzhou Medical University

Collaborator